Hepatitis vaccination among drug users

Gianluca Quaglio, Fabio Lugoboni, Paolo Mezzelani, Don C. Des Jarlais, Alessandro Lechi

Research output: Contribution to journalReview article

Abstract

Hepatitis virus infections are traditionally a major health problem among drug users (DUs). Several factors may favor the rapid spread of hepatitis infection in this category of patients. HBV and HCV are easily transmitted through exposure to infected blood and body fluids. DUs often prepare and use drug solutions together. Many in the DU community are infected and this provides multiple opportunities for transmission to others. Many of these patients with chronic hepatitis virus infection are not aware of their infections and this facilitates the spread of the diseases. Viral hepatitis is not inevitable for DUs. Although multiple factors have prevented the development of vaccines for hepatitis C, both hepatitis A and hepatitis B can be prevented by immunization. The purpose of this overview is to summarize and discuss the hepatitis vaccination in this population.

Original languageEnglish (US)
Pages (from-to)2702-2709
Number of pages8
JournalVaccine
Volume24
Issue number15
DOIs
StatePublished - Apr 5 2006

Keywords

  • Drug users
  • HAV
  • HBV
  • HCV
  • Hepatitis vaccination

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Hepatitis vaccination among drug users'. Together they form a unique fingerprint.

  • Cite this

    Quaglio, G., Lugoboni, F., Mezzelani, P., Des Jarlais, D. C., & Lechi, A. (2006). Hepatitis vaccination among drug users. Vaccine, 24(15), 2702-2709. https://doi.org/10.1016/j.vaccine.2005.12.045